These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16685434

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Iida T, Yamaue H.
    Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
    [Abstract] [Full Text] [Related]

  • 23. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G, Wang ZY, Yin S.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 11; 86(14):943-6. PubMed ID: 16759530
    [Abstract] [Full Text] [Related]

  • 24. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)].
    Chen GL, Hu HD, Ma YJ, Li YG, Xue Q, Chen M, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun 11; 14(6):431-4. PubMed ID: 16792867
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M, Kamigaki T, Yamashita K, Hori Y, Hasegawa H, Kuroda D, Moriyama H, Nagata M, Ku Y, Kuroda Y.
    Oncol Rep; 2009 Aug 11; 22(2):337-43. PubMed ID: 19578774
    [Abstract] [Full Text] [Related]

  • 27. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
    Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, Black KL, Yu JS.
    Cancer Res; 2006 Sep 01; 66(17):8887-96. PubMed ID: 16951206
    [Abstract] [Full Text] [Related]

  • 28. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP, Weng YS, Wu QQ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 01; 28(9):646-9. PubMed ID: 17274366
    [Abstract] [Full Text] [Related]

  • 29. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 01; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunization with truncated sequence of Telomerase Reverse Transcriptase induces a specific antitumor response in vivo.
    Qiu J, Li GW, Sui YF, Sun YJ, Huang YY, Si SY, Ge W.
    Acta Oncol; 2007 Nov 01; 46(7):961-8. PubMed ID: 17917827
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.
    J Immunother; 2007 Nov 01; 30(8):789-97. PubMed ID: 18049330
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
    Vuckovic S, Abdul Wahid FS, Rice A, Kato M, Khalil D, Rodwell R, Hart DN.
    Exp Hematol; 2008 Nov 01; 36(11):1496-506. PubMed ID: 18715688
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH, Ye Q, Hu ZQ, Ye ZQ, Yu X, Shen GX.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):481-5. PubMed ID: 17147108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.